2,430
Views
8
CrossRef citations to date
0
Altmetric
Research Articles

Limited value of NT-proBNP as a prognostic marker of all-cause mortality in patients with heart failure with preserved and mid-range ejection fraction in primary care: A report from the swedish heart failure register

, , , , &
Pages 434-443 | Received 11 Feb 2019, Accepted 01 Oct 2019, Published online: 14 Nov 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Gonzalo Núñez-Marín, Diego Iraola, Miguel Lorenzo, Rafael De La Espriella, Sandra Villar, Enrique Santas, Gema Miñana, Juan Sanchis, Arturo Carratalá, Òscar Miró, Antoni Bayés-Genís & Julio Núñez. (2023) An update on utilising brain natriuretic peptide for risk stratification, monitoring and guiding therapy in heart failure. Expert Review of Molecular Diagnostics 23:6, pages 521-533.
Read now
Mingming Ma, Qiao Luo, Xiangnan Dong, Shuang Cui, Berthold Hocher, Shufei Zeng, Wenxue Liang, Qiang Li, Xiaoyi Chen, Xin Chen, Yu Meng, Yongping Lu, Deguang Yang & Lianghong Yin. (2021) N-terminal prohormone B-type natriuretic peptide variability acts as a predictor of poor prognosis in patients with cardiorenal syndrome type 2. Bioengineered 12:2, pages 12407-12419.
Read now
José María Verdu-Rotellar, Helene Vaillant-Roussel, Rosa Abellana, Lea Gril Jevsek, Radost Assenova, Djurdjica Kasuba Lazic, Peter Torsza, Liam George Glynn, Heidrun Lingner, Jacopo Demurtas, Beata Borgström, Sylvaine Gibot-Boeuf & Miguel Angel Muñoz. (2020) Precipitating factors of heart failure decompensation, short-term morbidity and mortality in patients attended in primary care. Scandinavian Journal of Primary Health Care 38:4, pages 473-480.
Read now

Articles from other publishers (5)

Tobias Schupp, Mohammad Abumayyaleh, Kathrin Weidner, Felix Lau, Alexander Schmitt, Marielen Reinhardt, Noah Abel, Jan Forner, Muharrem Akin, Mohamed Ayoub, Kambis Mashayekhi, Thomas Bertsch, Ibrahim Akin & Michael Behnes. (2024) Diagnostic and Prognostic Value of Aminoterminal Prohormone of Brain Natriuretic Peptide in Heart Failure with Mildly Reduced Ejection Fraction Stratified by the Degree of Renal Dysfunction. Journal of Clinical Medicine 13:2, pages 489.
Crossref
Mazen Hanna, Nowell M. Fine, Balarama Gundapaneni, Marla B. Sultan & Ronald M. Witteles. (2022) Improvements in Efficacy Measures With Tafamidis in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial. JACC: Advances 1:5, pages 100148.
Crossref
Blanka Morvai-Illés, Nóra Polestyuk-Németh, István Adorján Szabó, Magdolna Monoki, Luna Gargani, Eugenio Picano, Albert Varga & Gergely Ágoston. (2021) The Prognostic Value of Lung Ultrasound in Patients With Newly Diagnosed Heart Failure With Preserved Ejection Fraction in the Ambulatory Setting. Frontiers in Cardiovascular Medicine 8.
Crossref
Jack B. Lopuszynski, Alicia J. Downing, Colleen M. Finley & Maliha Zahid. (2021) Prognosticators of All-Cause Mortality in Patients With Heart Failure With Preserved Ejection Fraction. The American Journal of Cardiology 158, pages 66-73.
Crossref
Jacinthe Boulet, Emmanuelle Massie & Jean-Lucien Rouleau. (2021) Heart Failure With Midrange Ejection Fraction—What Is It, If Anything?. Canadian Journal of Cardiology 37:4, pages 585-594.
Crossref